A pharmaceutical company dedicated to the development and commercialization of therapeutic products using patented proprietary formulations and novel delivery systems and by seeking new indications for previously approved pharmaceutical products.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
There are currently 1000 VVUS shares in my fund with break-even of around -24.08 USD.
http://caps.fool.com/Blogs/fund-trades/705717.
now 750 shares in the fund with break-even of around -37.05 USD.
http://caps.fool.com/Blogs/fund-trades/711929.
http://twitter.com/portefeuillefun.
now 650 shares in the fund with break-even of around -45.99 USD.
see this post.
http://caps.fool.com/Blogs/vvus/713217.